Ingevity Corporation $NGVT Shares Acquired by Pacer Advisors Inc.

Pacer Advisors Inc. boosted its holdings in Ingevity Corporation (NYSE:NGVT) by 4.5% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 170,543 shares of the company’s stock after buying an additional 7,315 shares during the quarter. Pacer Advisors Inc. owned 0.49% of Ingevity worth $12,148,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in the business. AQR Capital Management LLC lifted its position in shares of Ingevity by 10.9% during the 1st quarter. AQR Capital Management LLC now owns 13,410 shares of the company’s stock valued at $518,000 after acquiring an additional 1,323 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in shares of Ingevity by 5.2% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 21,790 shares of the company’s stock worth $863,000 after acquiring an additional 1,080 shares during the last quarter. Empowered Funds LLC raised its position in shares of Ingevity by 12.9% during the first quarter. Empowered Funds LLC now owns 5,181 shares of the company’s stock worth $205,000 after purchasing an additional 594 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its position in shares of Ingevity by 311.8% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 600,380 shares of the company’s stock worth $23,769,000 after purchasing an additional 454,579 shares during the period. Finally, Jane Street Group LLC lifted its holdings in shares of Ingevity by 306.1% during the first quarter. Jane Street Group LLC now owns 88,883 shares of the company’s stock valued at $3,519,000 after purchasing an additional 66,995 shares during the last quarter. Institutional investors and hedge funds own 91.59% of the company’s stock.

Ingevity Trading Up 2.8%

Ingevity stock opened at $75.47 on Wednesday. Ingevity Corporation has a 52 week low of $45.66 and a 52 week high of $79.29. The company has a debt-to-equity ratio of 22.52, a quick ratio of 1.15 and a current ratio of 1.61. The firm has a market capitalization of $2.59 billion, a price-to-earnings ratio of 51.34 and a beta of 1.16. The company has a 50 day moving average price of $72.03 and a 200 day moving average price of $71.13.

Ingevity (NYSE:NGVT) last announced its earnings results on Wednesday, July 29th. The company reported $1.74 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.33 by $0.41. The company had revenue of $314.10 million for the quarter, compared to the consensus estimate of $312.20 million. Ingevity had a net margin of 4.65% and a return on equity of 284.70%. Ingevity has set its FY 2026 guidance at 5.000-5.450 EPS. Research analysts forecast that Ingevity Corporation will post 5.4 EPS for the current year.

Analyst Ratings Changes

NGVT has been the subject of a number of recent analyst reports. Weiss Ratings upgraded Ingevity from a “sell (d-)” rating to a “hold (c-)” rating in a research report on Friday. Wall Street Zen downgraded Ingevity from a “strong-buy” rating to a “buy” rating in a report on Saturday. Two equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat.com, the company has an average rating of “Hold” and an average price target of $80.00.

Insiders Place Their Bets

In related news, SVP Ryan C. Fisher sold 2,709 shares of the company’s stock in a transaction on Monday, August 3rd. The stock was sold at an average price of $73.72, for a total transaction of $199,707.48. Following the transaction, the senior vice president directly owned 15,722 shares of the company’s stock, valued at approximately $1,159,025.84. The trade was a 14.70% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Terrance M. Dyer sold 496 shares of the company’s stock in a transaction on Thursday, May 28th. The shares were sold at an average price of $68.49, for a total value of $33,971.04. Following the transaction, the senior vice president directly owned 7,202 shares in the company, valued at $493,264.98. The trade was a 6.44% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 0.88% of the company’s stock.

Ingevity Company Profile

Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.

The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.